Dr. Michael Ringel is Chief Operating Officer at Life Biosciences, a company focused on cellular rejuvenation to reverse diseases of aging. Prior to joining Life Bio, Dr. Ringel was Managing Director and Senior Partner at BCG, where he worked for 25 years.
He is on the Board of Hevolution Foundation US, the charitable organization focused on extending healthy aging, the Board of AFAR, one of the oldest organizations supporting healthy aging through biomedical research, and on the Executive Board of the Sheba Longevity Center, a clinic devoted to healthy aging at one of the world’s best hospitals.
Dr. Ringel holds a B.A. summa cum laude in biology from Princeton University, a Ph.D. in biology from Imperial College, and a J.D. cum laude from Harvard Law School.